These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22816084)

  • 1. Absolute bioavailability of himantane in rabbits.
    Litvin EA; Bastrygin DV; Kolyvanov GB; Alekseev KV; Zherdev VP
    Bull Exp Biol Med; 2012 Jun; 153(2):206-8. PubMed ID: 22816084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretion of himantane and its metabolites with the urine and feces in rats.
    Litvin EA; Bastrygin DV; Kolyvanov GB; Alekseyev KV; Zherdev VP
    Bull Exp Biol Med; 2012 Aug; 153(4):481-2. PubMed ID: 22977850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of hemantane in rats].
    Litvin EA; Bastrygin DV; Kolyvanov GB; Alekseev KV; Zherdev VP
    Eksp Klin Farmakol; 2011; 74(11):24-8. PubMed ID: 22288156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the distribution of 3[H]-himantane in the brain structures and the thymus of rats].
    Kovalev GI; Rodionov AP; Petrenko ES; Zolotarev IuA
    Eksp Klin Farmakol; 2003; 66(3):50-2. PubMed ID: 12924235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MS.
    Xu XS; Dueker SR; Christopher LJ; Lohstroh PN; Keung CF; Cao KK; Bonacorsi SJ; Cojocaru L; Shen JX; Humphreys WG; Stouffer B; Arnold ME
    Bioanalysis; 2012 Aug; 4(15):1855-70. PubMed ID: 22943617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration.
    Yeung PK; Mosher SJ; Pollak PT
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):69-74. PubMed ID: 1936064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the prolonged immunotropic effect of the potential antiparkinson agent himantane].
    Nezhinskaia GI; Val'dman EA; Nazarov PG; Sapronov NS
    Eksp Klin Farmakol; 2003; 66(3):44-6. PubMed ID: 12924233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiparkinsonian drug himantane on the content of dopamine transporter DAT protein in rat striatum and cultured pheochromocytoma PC-12 cells.
    Abaimov DA; Zenina-Antipova TA; Kovalev GI; Seredenin SB
    Bull Exp Biol Med; 2008 Mar; 145(3):331-3. PubMed ID: 19039936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral absorption and presystemic first-pass effect of chlorpheniramine in rabbits.
    Huang SM; Huang YC; Chiou WL
    J Pharmacokinet Biopharm; 1981 Dec; 9(6):725-38. PubMed ID: 7341757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH; Lee MG
    Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotropic activity of a potential antiparkinson agent himantane].
    Nezhinskaia GI; Val'dman EA; Nazarov PG; Voronina TA
    Eksp Klin Farmakol; 2001; 64(2):60-3. PubMed ID: 11548451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of metabolites of ASP015K, a novel oral Janus kinase inhibitor, in rats, chimeric mice with humanized liver, and humans.
    Nakada N; Oda K
    Xenobiotica; 2015; 45(9):757-65. PubMed ID: 25869242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.
    Eichelbaum M; Somogyi A; von Unruh GE; Dengler HJ
    Eur J Clin Pharmacol; 1981 Jan; 19(2):133-7. PubMed ID: 7202473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
    Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
    Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of himantane on the rat embryo development].
    Durnev AD; Smol'nikova NM; Nemova EP; Val'dman EA; Avdiunina NI; Piatin BM; Seredenin SB
    Eksp Klin Farmakol; 2003; 66(6):32-5. PubMed ID: 14743708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity-based analytical approaches to support human absolute bioavailability studies.
    Xu XS; Jiang H; Christopher LJ; Shen JX; Zeng J; Arnold ME
    Bioanalysis; 2014 Feb; 6(4):497-504. PubMed ID: 24568352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of (-)-epicatechin in rabbits.
    Chen YA; Hsu KY
    Arch Pharm Res; 2009 Jan; 32(1):149-54. PubMed ID: 19183888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.